ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Sopharma Trading AD's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2024 was 11.01%.
As of today (2025-07-12), Sopharma Trading AD's WACC % is 6.22%. Sopharma Trading AD's ROIC % is 13.48% (calculated using TTM income statement data).
Sopharma Trading AD generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
Sopharma Trading AD ROIC % Historical Data
The historical data trend for Sopharma Trading AD's ROIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sopharma Trading AD's ROIC %
For the Medical Distribution subindustry, Sopharma Trading AD's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma Trading AD's ROIC % Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's ROIC % distribution charts can be found below:
* The bar in red indicates where Sopharma Trading AD's ROIC % falls into.
Note:
The Operating Income data used here is four times the quarterly (Dec. 2024) data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma Trading AD (XBUL:SFT) ROIC % Explanation
ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROIC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Sopharma Trading AD's WACC % is 6.22%. Sopharma Trading AD's ROIC % is 13.48% (calculated using TTM income statement data).
Sopharma Trading AD generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
Sopharma Trading AD earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Sopharma Trading AD ROIC % Related Terms
Thank you for viewing the detailed overview of Sopharma Trading AD's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBUL:SFT has been successfully added to your 